Privia Health Group, Inc. Common Stock (PRVA) is a publicly traded Healthcare sector company. As of November 18, 2026, PRVA trades at $25.27 with a market cap of $3.23B and a P/E ratio of 88.70. PRVA moved +1.92% today. Year to date, PRVA is +3.60%; over the trailing twelve months it is +7.71%. Its 52-week range spans $18.77 to $28.82. Analyst consensus is strong buy with an average price target of $30.43. Rallies surfaces PRVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PRVA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $25.27 |
| Market Cap | $3.23B |
| P/E Ratio | 88.70 |
| EPS | $0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.82 |
| 52-Week Low | $18.77 |
| Volume | 1.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.36B |
| Net Income | $33.84M |
| Gross Margin | 0.00% |
7 analysts cover PRVA: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.43.